Health Management Organizations

WHO (World Health Organization). 1989. Management and Control of the Environment. WHO/PEP/89.1. Geneva. 

Managed healthcare systems also have interests in reductionist definitions of disease. The payment and reimbursement structures of Health Management Organizations (HMOs) require that conditions be identified and coded in terms of a predefined list of syndromes with pre-established measures of cost and risk. Calling for evidence-based medicine , HMOs are more likely to reimburse conditions that are defined as biological because diagnosis appears objective. 

We found that an aspirant to top performance, whether in chemicals or other industries, must follow a balanced approach to the management of performance., i.e., what the organization needs to accomplish today, and health, or how it can improve or adjust its performance over time. Integrated performance and health management enables an organization to deliver value today while simultaneously... 

Our research shows that organizations should adhere to six principles in order to build an effective performance and health management system, centered around metrics, targets, reviews, links, rhythm, and culture. 

Dr. Quint has put herself in the position of Home TPN Care s controller. Her bonus, and that of her boss, the health system s vice president, will be determined in part by Home TPN Care s income in comparison with the budget. She can see from budgets submitted in the past that the organization s management usually... 

WHO (in preparation). Protecting Surface Waters for Health Managing the Quality of Drinking-water Sources, World Health Organization, Geneva and IWA Publishing, London. 

Liebler JG, McConnell CR. Organizing. In Management Principles for Health Professionals. Aspen, Gaithersburg, MD, 1999. 

The U.S. Supreme Court in June 2004 imposed restricted litigation against Health Management Organizations (HMOs). Could further restrictions on the extent of permissible litigation be beneficial ... 

The existence of evidence demonstrating that BTXs can climb the food chain and pose a threat to higher organisms, including humans, emphasises the urgent need for research into the impacts of BTX and related toxins in the areas of public health, management of sustainable shellfisheries, detection of neurotoxins, and determining the impact of those toxins in marine ecosystems. 

Robinson, J.C. The future of managed care organization. Health Aff. 1999, Mar/April, 7-24. 

Merrill, R.A. Modernizing the FDA. An Incremental Revolution. Health Affairs, Mar/April, 1999 96-111. Robinson, J.C. The Future of Managed Care Organization. Health Affairs, Mar/April, 1999 7-24. 

Documents the economic impact of clinical pharmacy activities for use by organized health care managers, practitioners, institutions, and providers. 

Drug Topics. Montvale, NJ Advanstar Medical Economics Healthcare Communications. Semimonthly. ISSN 0012-6616. Informational articles on all phases of pharmacy for community and health-system pharmacists, Health Management Organization (HMO) and consultant pharmacists, chain headquarters executives and buyers, mail-order pharmacists, wholesalers, academia, and others. 

Conder JM et al., Solid phase microextraction fibers for estimating the toxicity and bioavailability of sediment-associated organic compounds, Aquat. Ecosystem Health Manage., 1, 387, 2004. 

---